Showing results (81-90 of 176) with videos related to
Sort By:
Pageof 18
Bone Marrow Transplantation|November 21, 2012
Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplantT L Parker, D L Cooper, S E Seropian, et al.Cancer|August 1, 1992
Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acidD L Cooper, A B Sandler, L D Wilson, et al.Journal of the American Venereal Disease Association|December 1, 1976
Gonorrhea screening program in a women's hospital outpatient department: results and analysis of risk factorsD L Cooper, G S Bernstein, D Ivler, et al.The Journal of Biological Chemistry|March 25, 1994
Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1G J Dougherty, D L Cooper, J F Memory, et al.Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|December 20, 1999
Differential expressions of CD44 variants in tumors affecting the central nervous systemD K Resnick, N M Resnick, W C Welch, et al.Nature Methods|December 22, 2018
Detection of splice isoforms and rare intermediates using multiplexed primer extension sequencingHansen Xu, Benjamin J Fair, Zachary W Dwyer, et al.The Journal of Experimental Medicine|July 1, 1991
Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cellsG J Dougherty, P M Landorp, D L Cooper, et al.Southern Medical Journal|January 1, 1994
Cardiogenic shock due to progression of cutaneous T-cell lymphomaD L Cooper, J H Sinard, R L Edelson, et al.Faraday Discussions|October 9, 2004
Target isotope effects for vibrationally-resolved electron capture in low-energy collisions of O3+ with molecular hydrogenP C Stancil, J G Wang, A R Turner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Second solid malignancies after combined modality therapy for Hodgkin's diseaseR Doria, T Holford, L R Farber, et al.Pageof 18